- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Paul Wicks Points to the Benefits of Technology in MS Research
Paul Wicks, PhD, vice president of innovation at PatientsLikeMe, discussed the benefits of using technology in multiple sclerosis research by patients, providers, researchers, and other decision-makers.
Paul Wicks, PhD, vice president of innovation at PatientsLikeMe, discussed the benefits of using technology in multiple sclerosis research by patients, providers, researchers, and other decision-makers.
According to Dr Wicks, while many are skeptical of Internet-based information when researching multiple sclerosis symptoms and treatments, meaningful data is becoming increasingly accessible to patients. For instance, many patients are sharing patient-reported outcomes measures just like those used in clinical trials. Others are using web-based tools to pool together valid observational data. Dr Wicks was hopeful that this trend will grow over the next few years, and patients will become more confident in Internet-based research.
Dr Wicks also commented on the use of technology in MS research by providers and other healthcare professionals, particularly in the form of data-sharing. He proposed a system where every patient with MS is a “continuous data point,” where his or her data is recorded and used to make informed treatment decisions about others with similar symptoms. As Dr Wicks put it, “The point of technology is to support the learning healthcare system…for every patient that comes in the door, the decisions about their treatment will be made.”
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
sGFAP May Predict Progression Independent of Relapse in BCDT-Treated MS
November 29th 2024The findings show that increases in serum glial fibrillary acidic protein throughout B-cell depletion therapy are associated with disability worsening despite not relapsing—known as progression independent of relapse activity.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
